Download PDF
Aktuelle Kardiologie 2013; 2(1): 37-42
DOI: 10.1055/s-0032-1328157
Übersichtsarbeit
Georg Thieme Verlag KG Stuttgart · New York

Therapie häufiger neurologischer Erkrankungen bei kardiologischen Patienten

Treatment of Neurological Diseases in Cardiac Patients
Mario Siebler
1   Klinik für Neurologie und Rehabilitation, Mediclin Fachklinik Rhein/Ruhr, Essen-Kettwig, Universität Düsseldorf
,
Roger Marx
2   Klinik für Kardiologie und Rehabilitation, Mediclin Fachklinik Rhein/Ruhr, Essen-Kettwig, Universität Witten/Herdecke
› Author Affiliations
Further Information

Publication History

Publication Date:
20 February 2013 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die Komorbidität von kardiologischen und neurologischen Erkrankungen betrifft vorwiegend vaskuläre Prozesse mit Endorganischämien und erfordert spezialisierte Akuttherapien. Die Sekundärprävention der Arteriosklerose ist in beiden Disziplinen ähnlich, während die Antikoagulation auf einer neurologischen Indikation bei VHF und anderen kardialen Thrombenrisiken beruht. Sehr häufig sind erworbene QTc-Verlängerungen durch Pharmakointeraktionen neurologischer und kardiologischer Medikamente. Nach kardiologischen Erkrankungen (CPR, multiple Insulte) sind neuropsychologische Defizite oft unterdiagnostiziert und untertherapiert.

Abstract

The increasing comorbidity of cardiological and neurological diseases is mainly based on vascular processes with ischemic damage of the brain or heart tissue. They require a highly specialised acute treatment (Chest/Stroke Unit). Secondary prevention is often identical except of stroke prevention by anticoagulation in cardiac disease (e.g. AF). Long QTc syndromes caused by interaction of neuro-psychiatric drugs are frequent and underestimated with regard to their impact. Neuropsychological deficits are underdiagnosed in cardiac patients especially after CRP and multiple (silent) strokes.

Schlüsselwörter

Schlaganfall - Prävention - kognitive Störungen nach Reanimation - PFO

Key words

stroke - prevention - cognitive deficits after CRP - PFO
 

  • Literatur

  • 1 Leitlinien der Deutschen neurologischen Gesellschaft:. http://www.dgn.org
    PubMedGoogle Scholar
  • 2 Tekle WG, Chaudhry SA, Fatima Z et al. Intravenous Thrombolysis in Expanded Time Window (3–4.5 hours) in General Practice with Concurrent Availability of Endovascular Treatment. J Vasc Interv Neurol 2012; 5: 22-26
    PubMedGoogle Scholar
  • 3 Seifert M, Ahlbrecht A, Dohmen C et al. Combined interventional stroke therapy using intracranial stent and local intraarterial thrombolysis (LIT). Neuroradiology 2011; 53: 273-282
    CrossrefPubMedGoogle Scholar
  • 4 Taschner CA, Treier M, Schumacher M et al. Mechanical thrombectomy with the Penumbra recanalization device in acute ischemic stroke. Neuroradiol 2011; 38: 47-52
    CrossrefPubMedGoogle Scholar
  • 5 Nogueira RG, Smith WS. Safety and efficacy of endovascular thrombectomy in patients with abnormal hemostasis: pooled analysis of the MERCI and multi MERCI trials. Stroke 2009; 40: 516-522
    CrossrefPubMedGoogle Scholar
  • 6 Galimanis A, Jung S, Mono ML et al. Endovascular therapy of 623 patients with anterior circulation stroke. J Stroke 2012; 43: 1052-1057
    PubMedGoogle Scholar
  • 7 Ovbiagele B, Diener HC, Yusuf S et al. Level of systolic blood pressure within the normal range and risk of recurrent stroke. JAMA 2011; 306: 2137-2144
    CrossrefPubMedGoogle Scholar
  • 8 Mills EJ, Wu P, Chong G et al. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials. QJM 2011; 104: 109-124
    CrossrefPubMedGoogle Scholar
  • 9 Kwon SU, Hong KS, Kang DW et al. Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis. Stroke 2011; 42: 2883-2890
    CrossrefPubMedGoogle Scholar
  • 10 Kasner SE, Lynn MJ, Chimowitz MI et al. Warfarin Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Warfarin vs. aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology 2006; 67: 1275-1278
    CrossrefPubMedGoogle Scholar
  • 11 Kasner SE, Lynn MJ, Chimowitz MI et al. Warfarin vs. aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology 2006; 67: 1275-1278
    CrossrefPubMedGoogle Scholar
  • 12 Furlan AJ, Reisman M, Massaro J et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 2012; 366: 991-999
    CrossrefPubMedGoogle Scholar
  • 13 Dowson A, Mullen MJ, Peatfield R et al. Migraine Intervention With STARFlex Technology (MIST) Trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008; 117: 1397-1404
    CrossrefPubMedGoogle Scholar
  • 14 Rundek T, Elkind MS, Di Tullio MR et al. Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation 2008; 118: 1419-1424
    CrossrefPubMedGoogle Scholar
  • 15 Hofmeijer J, Kappelle LJ, Algra A et al. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol 2009; 8: 326-333
    CrossrefPubMedGoogle Scholar
  • 16 Powers WJ, Clarke WR, Grubb jr. RL et al. Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the Carotid Occlusion Surgery Study randomized trial. JAMA 2011; 306: 1983-1992
    CrossrefPubMedGoogle Scholar
  • 17 Bhattathiri PS, Gregson B, Prasad KS. Intraventricular hemorrhage and hydrocephalus after spontaneous intracerebral hemorrhage: results from the STICH trial. Acta Neurochir Suppl 2006; 96: 65-68
    PubMedGoogle Scholar
  • 18 Saczynski JS, Marcantonio ER, Quach L et al. Cognitive trajectories after postoperative Delirium. N Engl J Med 2012; 367: 30-39
    CrossrefPubMedGoogle Scholar
  • 19 Bluhmki E, von Kummer R, Brott TG et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375: 1695-1703
    CrossrefPubMedGoogle Scholar